Drug discovery of the future: the implications of the human genome project.
The elucidation of the 3.2-gigabase human genome will have various impacts on drug discovery. The number of drug targets will increase by at least one order of magnitude and target validation will become a high-throughput process. To benefit from these opportunities, a theory-based integration of the vast amount of new biological data into models of biological systems is called for. The skills and knowledge required for genome-based drug discovery of the future go beyond the traditional competencies of the pharmaceutical industry. Cooperation with biotechnology firms and research institutions during drug discovery and development will become even more important.
Reiss
T
T
Fraunhofer Institute for Systems and Innovation Research, Breslauer Str. 48, 76139, Karlsruhe, Germany. rt@isi.fhg.de
D019295:Computational Biology; D015195:Drug Design; D004345:Drug Industry; D015894:Genome, Human; D006801:Humans; D008954:Models, Biological